- Home
- XNCR vs BHE Comparison
XNCR vs BHE Comparison
Compare XNCR & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- BHE
- Stock Information
- Founded
- XNCR 1997
- BHE 1979
- Country
- XNCR United States
- BHE United States
- Employees
- XNCR N/A
- BHE N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- BHE Electrical Products
- Sector
- XNCR Health Care
- BHE Technology
- Exchange
- XNCR Nasdaq
- BHE Nasdaq
- Market Cap
- XNCR 1.7B
- BHE 1.7B
- IPO Year
- XNCR 2013
- BHE 1990
- Fundamental
- Price
- XNCR $24.20
- BHE $45.29
- Analyst Decision
- XNCR Strong Buy
- BHE Strong Buy
- Analyst Count
- XNCR 9
- BHE 3
- Target Price
- XNCR $36.33
- BHE $42.33
- AVG Volume (30 Days)
- XNCR 850.2K
- BHE 287.4K
- Earning Date
- XNCR 11-06-2024
- BHE 01-29-2025
- Dividend Yield
- XNCR N/A
- BHE 1.50%
- EPS Growth
- XNCR N/A
- BHE N/A
- EPS
- XNCR N/A
- BHE 1.72
- Revenue
- XNCR $85,164,000.00
- BHE $2,690,572,000.00
- Revenue This Year
- XNCR N/A
- BHE N/A
- Revenue Next Year
- XNCR $89.22
- BHE $4.51
- P/E Ratio
- XNCR N/A
- BHE $26.30
- Revenue Growth
- XNCR N/A
- BHE N/A
- 52 Week Low
- XNCR $15.31
- BHE $25.36
- 52 Week High
- XNCR $27.24
- BHE $52.57
- Technical
- Relative Strength Index (RSI)
- XNCR 44.92
- BHE 36.36
- Support Level
- XNCR $22.74
- BHE $45.47
- Resistance Level
- XNCR $25.54
- BHE $49.06
- Average True Range (ATR)
- XNCR 1.17
- BHE 1.52
- MACD
- XNCR -0.33
- BHE -0.43
- Stochastic Oscillator
- XNCR 22.00
- BHE 8.52
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.